PharmaCyte Biotech, Inc.

US$0.36As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:PMCBHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (39.51%)
Div yield —
ROE (43.99%)
Biotechnology
Beta (5Y) 0.77
PE TTM —
TSR TTM (61.29%)
Mkt cap US$3.865M
ROIC (9.30%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.394
9.32%
(89.27%)
Hold 0|4|3|0|12
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.01
0.01
0.01
0.01
14.12%
28.33%
38.47%
33.80%
Revenue$M
0.207
0.218
0.213
0.211
6.39%
12.45%
9.64%
5.55%
Peers (US$3.865M)
Cap (US$)
PE
4.110M
—
3.721M
—
3.863M
—
Capital
TTM
5Y
10Y
Leveragex
0.705
0.086
0.067
EBIT/Intx
0.292
1.001
0.929
Own earn%
(130.00)
35.12
55.10
Sh yield%
27.58
30.23
26.15
Owners
Insiders/Inst%
4.02
56.27
Short interest%
2.10
SBC / revenue%
4.11
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
3–8
$1 testx
0.1
Incr. ROIC%
37